Claudio Conforti

COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Claudio Conforti, Roberta Giuffrida, Caterina Dianzani et al. · Dermatologic Therapy · 2020 · 102 citations · Full text

Immunodeficiencies, Immunology, Pharmacotherapy +24

Doxycycline, a widely used antibiotic in dermatology with a possible anti‐inflammatory action against <scp>IL</scp> ‐6 in <scp>COVID</scp> ‐19 outbreak

Claudio Conforti, Roberta Giuffrida, Iris Zalaudek et al. · Dermatologic Therapy · 2020 · 46 citations · Full text

Inflammation, Possible Anti‐inflammatory Action, Health Sciences +15

<scp>COVID</scp> ‐19 and <scp>SARS</scp> : Differences and similarities

Antonio Caldaria, Claudio Conforti, Nicola di Meo et al. · Dermatologic Therapy · 2020 · 35 citations · Full text

Virus Epidemiology, Surgery, Covid-19 Epidemiology +26

Impact of the COVID-19 Pandemic on Dermatology Practice Worldwide: Results of a Survey Promoted by the International Dermoscopy Society (IDS)

Claudio Conforti, Aimilios Lallas, Giuseppe Argenziano et al. · Dermatology Practical & Conceptual · 2021 · 34 citations · Full text

The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?

Claudio Conforti, Francesca Paolini, Aldo Venuti et al. · British Journal of Dermatology · 2019 · 24 citations · Full text

Precancerous Lesions, Viral Diagnostics, Viral Pathogenesis +18